Multiple Myeloma in Relapse Completed Phase 2 Trials for Dextromethorphan (DB00514)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs